Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement

Journal of Thoracic and Cardiovascular Surgery

Volumn 144, Issue 1, 2012, Pages 146-151

  Chan, Vincent ^a   Lam, B Khanh ^a   Rubens, Fraser D ^a   Hendry, Paul ^a   Masters, Roy ^a   Mesana, Thierry G ^a   Ruel, Marc ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; ANTICOAGULANT THERAPY; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; CAUSE OF DEATH; CORONARY ARTERY BYPASS SURGERY; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART VALVE BIOPROSTHESIS; HUMAN; LONG TERM CARE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT PREFERENCE; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REOPERATION; RISK FACTOR; THROMBOEMBOLISM;

AORTIC VALVE; BIOPROSTHESIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; REOPERATION; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84862602810     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.08.041     Document Type: Article

References (23)

1. Chan V, Jamieson WR, Germann E, Chan F, Miyagishima RT, Burr LH, et al. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement. J Thorac Cardiovasc Surg. 2006;131:1267-73.
2. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve (final report of the Veterans Affairs randomized trial). J Am Coll Cardiol. 2000;36:1152-8.
3. Hammermeister K, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola SH. Veterans Affairs Cooperative Study on Valvular Heart Disease. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. N Engl J Med. 1993;328:1289-96.
4. Bloomfield P, Wheatley DJ, Prescott RJ, Miller HC. Twelve-year comparison of a Björk-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med. 1991;324:573-9.
5. Oxenham H, Blomfield P, Wheatley DJ, Lee RJ, Cunningham J, Prescott RJ, et al. Twenty-year comparison of the Björk-Shiley mechanical heart valve with porcine bioprostheses. Heart. 2003;89:715-21.
6. Ruel M, Kulik A, Lam BK, Rubens FD, Hendry PJ, Masters RG, et al. Long-term outcomes of valve replacement with modern prostheses in young adults. Eur J Cardiothorac Surg. 2005;27:425-33.
7. Ruel M, Chan V, Bédard P, Kulik A, Ressler L, Lam BK, et al. Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults <60 years of age. Circulation. 2007;116(11 Suppl): I294-300.
8. Webb JG, Wood DA, Ye J, Gurvitch R, Masson JB, Rodés-Cabau J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121:1848-57.
9. Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, et al. Councils of the American Association for Thoracic Surgery; Society of Thoracic Surgeons; European Association for Cardio-Thoracic Surgery; Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008;135:732-8.
10. Kumar P, Athanasiou T, Ali A, Nair S, Oz BS, DeSouza A, et al. Re-do aortic valve replacement: does a previous homograft influence the operative outcome? J Heart Valve Dis. 2004;13:904-12; discussion 912-3.
11. Brandao CMA, Pomerantzeff PMA, Souza LR, Tarasoutchi F, Grimberg M, Antonio J, et al. Multivariate analysis of risk factors for hospital mortality in valvular reoperations for prosthetic valve dysfunction. Eur J Cardiothorac Surg. 2002;22:922-6.
12. Piehler JM, Blackstone EH, Bailey KR, Sullivan ME, Pluth JR, Weiss NS, et al. Reoperation on prosthetic heart valves: patient-specific estimates of in-hospital events. J Thorac Cardiovasc Surg. 1995;109:30-48.
13. Potter DD, Sundt TM 3rd, Zehr KJ, Dearani JA, Daly RC, Mullany CJ, et al. Operative risk of reoperative aortic valve replacement. J Thorac Cardiovasc Surg. 2005;129:94-103.
14. Dalrymple-Hay MJ, Crook T, Bannon PG, Ohri SK, Haw MP, Bayfield MS, et al. Risk of reoperation for structural failure of aortic and mitral tissue valves. J Heart Valve Dis. 2002;11:419-23.
15. Leontyev S, Borger MA, Modi P, Lehmann S, Seeburger J,Walther T, et al. Redo aortic valve surgery: influence of prosthetic valve endocarditis on outcomes. J Thorac Cardiovasc Surg. 2011;142:99-105. [Epub 2010 Oct 15].
16. Maganti M, Rao V, Armstrong S, Feindel CM, Scully HE, David TE. Redo valvular surgery in elderly patients. Ann Thorac Surg. 2009;87:521-5.
17. Chan V, Jamieson WR, Lam BK, Ruel M, Ling H, Fradet G, et al. Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study. J Thorac Cardiovasc Surg. 2010;140:1053-8.
18. Bryan AJ, Rogers CA, Bayliss K, Wild J, Angelini GD. Prospective randomized comparison of CarboMedics and St Jude Medical bileaflet mechanical heart valve prostheses: ten-year follow-up. J Thorac Cardiovasc Surg. 2007;133:614-22.
19. Buresly K, Eisenberg MJ, Zhang X, Pilote L. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med. 2005;165:784-9.
20. Shaikhrezai K, Tasca G, Amrani M, Dreyfus G, Asimakopoulos G. Third-time aortic valve replacement: patient characteristics and operative outcome. Ann Thorac Surg. 2010;89:479-83.
21. Masters RG, Walley VM, Pipe AL, Keon WJ. Long-term experience with the Ionescu-Shiley pericardial valve. Ann Thorac Surg. 1995;60:S288-91.
22. Blot WJ, Signorello LB, Cohen SS, Ibrahim MA. Single leg separation prevalence among explanted Björk-Shiley prosthetic heart valves. J Heart Valve Dis. 2007;16:657-61.
23. Kallewaard M, Algra A, Defauw J, van der Graaf Y. Which manufacturing characteristics are predictors of outlet strut fracture in large sixty-degree Björk-Shiley convexo-concave mitral valves? The Björk-Shiley Study Group. J Thorac Cardiovasc Surg. 1999;117:766-75.